298 related articles for article (PubMed ID: 25754701)
1. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
Yang JQ; Chen XY; Engle MY; Wang JY
Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.
Weisberg NK; Varghese M
Dermatol Surg; 2002 Jun; 28(6):518-23. PubMed ID: 12081683
[TBL] [Abstract][Full Text] [Related]
3. Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream.
Nagore E; Sevila A; Sanmartin O; Botella-Estrada R; Requena C; Serra-Guillen C; Sanchez-Pedreño P; Guillen C
Br J Dermatol; 2003 Oct; 149(4):858-61. PubMed ID: 14616381
[TBL] [Abstract][Full Text] [Related]
4. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.
Roseeuw D
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():30-2. PubMed ID: 14616810
[TBL] [Abstract][Full Text] [Related]
5. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
[TBL] [Abstract][Full Text] [Related]
6. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream.
Malhotra AK; Gupta S; Khaitan BK; Verma KK
Pediatr Dermatol; 2008; 25(4):488-91. PubMed ID: 18789101
[TBL] [Abstract][Full Text] [Related]
7. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
[TBL] [Abstract][Full Text] [Related]
9. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
Marks R; Owens M; Walters SA;
Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
[No Abstract] [Full Text] [Related]
11. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
Oster-Schmidt C; Altmeyer P; Stücker M
Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
[No Abstract] [Full Text] [Related]
12. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
Shulstad RM
Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
14. A patient with xeroderma pigmentosum treated with imiquimod 5% cream.
Nijsten T; Lapière K; Lambert J
J Am Acad Dermatol; 2005 Jan; 52(1):170-1. PubMed ID: 15627108
[No Abstract] [Full Text] [Related]
15. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
Hannuksela-Svahn A; Nordal E; Christensen OB
Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
[No Abstract] [Full Text] [Related]
16. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
[No Abstract] [Full Text] [Related]
17. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
18. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
[TBL] [Abstract][Full Text] [Related]
19. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
[No Abstract] [Full Text] [Related]
20. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
